Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,001–2,025 of 27,380 studies, newest first · page 81 of 1096.

January 2026 25

  1. 2026-01-01

    Blood-based analysis of different tau variants in patients with multiple traumatic injuries

    ✓ Peer-reviewed Tau biomarkers Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt)

    Key finding: Median serum levels of tau variants were increased in patients with multiple traumatic injuries at day 0 compared with controls (t-tau: 43 [IQR, 21-95] vs 3 [IQR, 3-5] pg/mL; BD-tau: 78 [IQR, 30-343] vs 2 [IQR, 2-3] pg/mL; p-tau231: 61 [IQR, 21-79] vs 2 [IQR, 1-3] pg/mL; all, P < .001). +1 more finding

  2. 2026-01-01

    In silico structure-based multi-targeted molecular docking analysis of ginkgo biloba phytocompounds against Alzheimer’s disease associated proteins

    ✓ Peer-reviewed Risk genes beyond APOE In Silico Research in Biomedicine

    Key finding: Analysis of interaction showed that hydrogen bonding and hydrophobic contacts were found in the specified binding areas.

  3. 2026-01-01

    IMAGING OF THE BONE ARCHITECTURE IN THE CONTEXT OF ALZHEIMER DISEASE

    ✓ Peer-reviewed Risk genes beyond APOE Osteoarthritis Imaging

    Key finding: Female Psen1 mutation(L166P) mice were found to have reductions in whole-body mineral density (BMD) and bone mineral content as early as one month and a sustained bone phenotype with age with loss in cortical and trabecular properties compared to age-and gendermatched wildtype control mice, whereas male mice did not (Fig.1A-C). +4 more findings

  4. 2026-01-01
  5. 2026-01-01

    Rationale and design of a multidomain lifestyle program for mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia

    Key finding: CEP comprises four cores (Therapeutic Programs, Technology, Built Environment, and Innovation Accelerator) that map to the conceptual framework. +4 more findings

  6. 2026-01-01

    Individualized prediction of transition from subjective cognitive decline to mild cognitive impairment based on multimodal MRI: a 10-year follow-up study

    ✓ Peer-reviewed Mild cognitive impairment The Journal of Prevention of Alzheimer s Disease

    Key finding: The model incorporating age, brain volume, functional, and radiomics features demonstrated the highest predictive performance for SCD progression in training (C-index: 0.962; 95 % CI: 0.95-0.98) and testing (C-index: 0.911; 95 % CI: 0.861-0.968) sets. +4 more findings

  7. 2026-01-01

    Preclinical Catecholaminergic Biomarkers of Central Lewy Body Diseases

    ✓ Peer-reviewed Lewy body dementia Journal of Clinical Neurology

    Key finding: In the central Lewy body diseases (LBDs) Parkinson's disease and dementia with Lewy bodies (DLB), by the time parkinsonism or cognitive dysfunction manifests, substantial central neurodegeneration has already occurred. +4 more findings

  8. 2026-01-01

    EEG network reorganization across Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

    Key finding: AD showed canonical slowing with delta/theta increases and posterior alpha loss. +3 more findings

  9. 2026-01-01

    Vascular dementia: World Stroke Organization fact sheet 2026

    ✓ Peer-reviewed Lewy body dementia International Journal of Stroke

    Key finding: Despite the importance of VaD, it remains underrecognized and underresearched compared to other forms of dementia.

  10. 2026-01-01

    Novel insights into Alzheimer's disease through the study of individuals with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Alzheimer s & Dementia

    Key finding: Novel insights into Alzheimer's disease through the study of individuals with Down syndromePeople with Down syndrome (DS) represent the largest genetically defined population at risk for Alzheimer's disease (AD). 1 Virtually all adults with DS develop AD neuropathology by midlife due to triplication

  11. 2026-01-01

    Midlife and late‐life population attributable fractions of risk factors for dementia in the United States: The Dementia Risk Prediction Project

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Midlife and late-life risk factors contributed to 22.7% and 16.5% of total dementia cases, respectively. +4 more findings

  12. 2026-01-01

    The potential for dementia prevention in Japan: a population attributable fraction calculation for 14 modifiable risk factors and estimates of the impact of risk factor reductions

    ✓ Peer-reviewed Risk factors The Lancet Regional Health - Western Pacific

    Key finding: The weighted combined PAF for all 14 risk factors was 38.9%, indicating that nearly 4 in 10 dementia cases in Japan might be preventable. +4 more findings

  13. 2026-01-01

    Lessons learned in the recruitment and retention of Black males in informal dementia caregiving research

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia

    Key finding: Of the n = 180 participants recruited, n = 77 participated in this study, n = 37 caregivers and n = 40 non-caregivers. +4 more findings

  14. 2026-01-01

    Beyond black‐box AI: Interpretable hybrid systems for dementia care

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

    Key finding: We propose a three-level framework for hybrid AI integration: (1) knowledge retrieval with linked citations; (2) contextualized decision support that combines predictive models with actionable plans derived from expert rules; and (3) adaptive optimization through continuous feedback. +4 more findings

  15. 2026-01-01
  16. 2026-01-01
  17. 2026-01-01

    Alzheimer Detection And Classification Using SVM

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: This leads to more precise and stable classification results, even with smaller datasets compared to existing ML models, the proposed SVM model achieves higher accuracy, sensitivity, and specificity, making it more dependable for automatic Alzheimer's detection. +1 more finding

  18. 2026-01-01

    Alzheimer Detection And Classification Using SVM

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: This leads to more precise and stable classification results, even with smaller datasets compared to existing ML models, the proposed SVM model achieves higher accuracy, sensitivity, and specificity, making it more dependable for automatic Alzheimer's detection. +1 more finding

  19. 2026-01-01

    Longitudinal Structural MRI-Based Deep Learning And Radiomics Features For Predicting Alzheimer\\\\\\\'s Disease Progression

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: This paper presents a comprehensive review of a re-cent longitudinal MRI-based study by Aghajanian et al. [1], which integrates three-dimensional (3D) convolutional neural networks (CNNs), time-aware long short-term memory (T-LSTM) networks with attention mechanisms, and radiomics features to predic +4 more findings

  20. 2026-01-01

    Longitudinal Structural MRI-Based Deep Learning And Radiomics Features For Predicting Alzheimer\\\\\\\'s Disease Progression

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: This paper presents a comprehensive review of a re-cent longitudinal MRI-based study by Aghajanian et al. [1], which integrates three-dimensional (3D) convolutional neural networks (CNNs), time-aware long short-term memory (T-LSTM) networks with attention mechanisms, and radiomics features to predict MCI-to-AD conversion using structural MRI. +4 more findings

  21. 2026-01-01

    Multimodal Deep Learning for Dynamic and Static Neuroimaging: Integrating MRI and fMRI for Alzheimer Disease Analysis

    ✓ Peer-reviewed Brain scans and imaging Journal of Machine Learning for Modeling and Computing

    Key finding: Magnetic Resonance Imaging (MRI) provides detailed structural information, while functional MRI (fMRI) captures temporal brain activity. +1 more finding

  22. 2026-01-01

    Structural Brain Correlates With Appetite and Eating Disturbances Across the Alzheimer Disease Spectrum

    ✓ Peer-reviewed Brain scans and imaging Alzheimer Disease & Associated Disorders

    Key finding: Appetite disturbances were present in 9.4% of participants and were associated with greater neuropsychiatric burden and disease severity. +3 more findings

  23. 2026-01-01

    The Role of Lifestyle and Diet in the Treatment of Endometriosis: A Review

    ✓ Peer-reviewed Prevention and risk Nutrients

    Key finding: Endometriosis is a chronic, oestrogen-dependent inflammatory condition affecting approximately 10% of women of reproductive age, frequently associated with chronic pelvic pain, dysmenorrhoea and infertility, substantially impairing quality of life. +3 more findings

  24. 2026-01-01

    Prevalence of frailty and its association with cognition in preclinical Alzheimer’s disease: a cross-sectional analysis of baseline data from the A4 study

    ✓ Peer-reviewed Treatments Age and Ageing

    Key finding: Four thousand four hundred eighty-six participants were included (mean age 71.3 ± 4.7 years, 30% participants Aβ+, 59% female). +4 more findings

  25. 2026-01-01

    Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy

    ✓ Peer-reviewed Treatments Dementia and Neurocognitive Disorders

    Key finding: In contrast, amyloid-β monoclonal antibodies have provided proof that biomarker-confirmed early AD can be slowed, although the magnitude of clinical benefit is modest, treatment is restricted to carefully selected patients, and amyloid-related imaging abnormalities require structured monitoring. +4 more findings

Browse the library by subject, with the full score breakdown →